Cape Town, South Africa. O B J E C T I V E : To compare the diagnostic yield for smear/ culture and Xpert w MTB/RIF algorithms and to investigate the mechanisms influencing tuberculosis (TB) yield.
identical conditions indicated a 13.3% increase in diagnostic yield from the Xpert algorithm compared to smear/culture. The model demonstrated that the extensive use of culture in the smear/culture algorithm and the decline in TB prevalence are the main factors contributing to not finding an increase in diagnostic yield in the routine data. C O N C L U S I O N : We demonstrate the benefits of an operational model to determine the effect of scale-up of a new diagnostic algorithm, and recommend that policy makers use operational modelling to make appropriate decisions before new diagnostic algorithms are scaled up. K E Y W O R D S : TB diagnostic yield; modelling; simulation; TB diagnosis TUBERCULOSIS (TB) remains a major cause of morbidity and mortality worldwide. Of the global estimated 10.4 million incident TB cases in 2015, 1.2 million were infected with the human immunodeficiency virus (HIV). 1 The Africa region accounted for 26% of global TB cases, 31% of whom are estimated to be HIV-co-infected. The main contributing factor driving the TB epidemic is ongoing transmission due to undiagnosed TB cases, diagnosed cases not initiating treatment [2] [3] [4] and diagnostic and treatment initiation delays. 5, 6 Increased investment in recent years has resulted in a number of new, more sensitive and rapid diagnostic tests for TB, with the expectation that this would lead to an increase in the number of cases diagnosed and earlier diagnosis and initiation of treatment, thus reducing transmission and, ultimately, the burden of disease. One of these tests, the Xpert w MTB/RIF assay (Cepheid, Sunnyvale, CA, USA), was endorsed by the World Health Organization (WHO) and recommended as the initial diagnostic test for those with suspected multidrug-resistant TB (MDR-TB) or HIV-associated pulmonary TB (PTB). 7 South Africa replaced smear microscopy with Xpert as the first test in the diagnostic algorithm for all presumptive PTB cases in 2011. 8 The decision by policy makers about which new test to implement in a diagnostic algorithm can be complicated, and factors to be considered include the best combination of diagnostic tests, the resources required, who should be tested and the TB epidemiology in the setting (prevalence of TB, HIV coinfection and drug resistance). Often many of these factors are not known, and expensive and timeconsuming clinical trials are required to make informed decisions, 9 or decisions are made without all the necessary information.
The variable results reported from studies evaluating the implementation of Xpert highlight the complexity in deciding if and how a new diagnostic test should be implemented within a diagnostic algorithm. For example, a population-level decision model estimated that full Xpert coverage would identify 30% more TB cases (with yield increasing from 15% to 19%) in South Africa in 2013 compared to smear and culture. 10 A prospective cluster-randomised trial of Xpert compared to smear microscopy and culture conducted in a primary care clinic in Cape Town, South Africa, showed an increase in TB yield from 17% with smear and culture to 26% with Xpert. 11 A study conducted in North Ethiopia among household contacts of TB index cases showed an increase of 64.3% in TB detection between smear microscopy (12.8%) and Xpert (35.9%). 12 However, other studies in South Africa and Zimbabwe have not found increases in TB yield. 13, 14 Xpert is expensive to implement and use, and the health system and patient impacts and benefits under routine operational conditions are still uncertain.
Modelling as a framework to help with decision making is an attractive and viable option to guide policy makers in implementing new diagnostic tests and algorithms. Operational modelling could identify gaps within a health system and options for addressing these. 15 Projections of the impact of interventions on patient access and outcomes and health system costs and infrastructure could help guide policy makers on which new diagnostic tests and algorithms should be implemented.
As part of an evaluation of new TB diagnostics in South Africa (Policy Relevant Outcomes from Validating Evidence on ImpacT, PROVE IT), we developed an operational model using a discrete event simulation approach for the previous smear/culturebased TB diagnostic algorithm and the newly introduced Xpert-based algorithm in Cape Town and validated the model outputs by comparing these with routine TB programme data. 16 We used the operational model to investigate the mechanisms influencing TB yield in our setting and to better understand why we did not find the expected increase in TB diagnostic yield in our own empirical study. 16 We used simulated model scenarios, including a decrease in TB prevalence, varying adherence to protocol in diagnostic algorithms and knowledge of HIV status to make direct comparisons of the proportion of presumptive cases diagnosed as TB (TB yield), missed cases (false-negatives) and unnecessarily treated cases (false-positives) in the smear/ culture and Xpert-based algorithms.
METHODS

Setting
The model was developed (Appendix Tables A.1 Table A. 3) using routine National Health Laboratory Service (NHLS) data collected for the period from 2010 to 2013 over seven time points (T1 to T7) in Cape Town, 16 one of the larger cities in South Africa, with a population of 3.7 million in 2011 (national census 2011) and 28 658 TB cases reported; 47% of TB cases tested were co-infected with HIV (source: routine TB programme data, Cape Town Health Directorate).
Municipal and provincial health authorities provided TB diagnostic services at 142 primary health care (PHC) facilities. Sputum samples collected for TB testing at PHC facilities were couriered to the central NHLS on a daily basis for testing, and results were returned via courier and fax.
Two diagnostic algorithms (Appendix Figure A.1) were used in the study period. A smear/culture-based TB algorithm was used before August 2011, with all presumptive cases required to submit two spot sputum samples taken at least 1 h apart. Both sputum samples were examined using fluorescence microscopy after being chemically treated, centrifuged and stained. Among previously treated presumptive cases, the second sample was cultured using BACTECe MGITe 960 (BD, Sparks, MD, USA) and tested for drug susceptibility using the GenoType w MTBDRplus (Hain LifeScience, Nehren, Germany) line-probe assay (LPA). For new presumptive cases who were smear-negative and HIV-infected, a third sample was required for culture.
An Xpert-based algorithm was phased in from August 2011 to February 2013, with Xpert replacing smear microscopy for all presumptive cases. The first of two sputum samples submitted was tested using Xpert. If TB was detected, smear microscopy was performed on the second sample. In HIV-infected cases with negative Xpert results, the second sample underwent culture and LPA. All definitions for terms used throughout the article are given in Table 1 .
Model development
The Witness package, a discrete event and continuous process simulator, 17 was used to develop a comprehensive model to represent the diagnosis of PTB in Cape Town. The model incorporated TB diagnostic algorithms (Appendix Figure A. 1) as well as patient pathways and sample flow (Appendix Figure A. 2) from specimen collection through laboratory test procedures to a result being provided to the patient and treatment initiation. Table 2 summarises the model validation, and a detailed account of model development (Appendix Tables A.1 and A. 2), more details about validation (Appendix Table A. 3) as well as model sensitivity analysis, are available in the online Appendix.
Simulated scenarios: comparing the smear/culture and Xpert-based algorithms To determine why the expected increase in TB yield was not observed in our setting with the roll-out of the Xpert-based algorithm, we modelled both algorithms with identical input parameters to eliminate any differences in population characteristics (TB prevalence, HIV status, history of previous anti-tuberculosis treatment) during the time the smear/culture-based algorithm was in use and during the Xpert roll-out. We used estimated prevalence data from the most recent time point (T7) and an average of population parameters (proportion of previously treated cases and HIV status) over the seven time points. We ran the model for a period of 3 years for each simulation.
In the base-case scenario (Scenario A), we set levels of adherence to testing protocols in both algorithms at 85%, and assumed that 50% of presumptive cases knew their HIV status. Various other scenarios were modelled (Table 3 ) and, unless otherwise specified, the baseline parameters for Scenario A were maintained for all the following scenarios. In Scenario B, the estimated TB prevalence among presumptive TB cases was increased by 10%. In Scenario C, we increased the number of cultures for smear-negative and Xpert-negative presumptive TB cases to that found in routine practice: smear/culture-based algorithm: new HIV-negative 30% and HIV-positive 92%, previously treated HIV-negative 10% and HIV-positive 95%; Xpert-based algorithm: new HIV-negative 5% and HIV-positive 92%, previously treated HIV-negative 10% and HIV-positive 95%.
In Scenario D, we assessed the effect of an increase in known HIV status (from 50% to 85%) on outputs.
In Scenario E, we tested the effect of 100% adherence to testing protocols in each algorithm, with 50% of presumptive TB cases' HIV status known. With Scenario F, we increased both HIV status known and adherence to testing protocols to 100%. With Scenario G, the use of culture was removed from both algorithms, as in most settings culture is not used as extensively as in Cape Town or is not used at all as part of the diagnostic algorithm. In Scenario H, we lowered the test sensitivity of smear microscopy by 10%. Scenario input parameters are summarised in Appendix Tables A.4 and A.5. For each scenario, we compared TB yield between the algorithms for all TB cases, and also assessed the proportion of missed cases (false-negative or TB not detected but TB present) and cases treated unnecessarily (false-positive or TB detected but no TB present). We undertook Figure 1 Model output comparing observed yield and model yield for all presumptive cases. Figure 2 Model outputs from the scenarios comparing TB diagnostic yield (%) between algorithms and sensitivity of input parameters. Diagnostic yield from routine data. Model with routine data as input parameters. Scenario A: 85% adherence to algorithm and 50% of presumptive cases know their HIV status; Scenario B: increase estimated TB prevalence among presumptive cases by 10%; Scenario C: increase additional culture for smear or Xpert-negative presumptive cases per routine practice; Scenario D: increased proportion (85%) of presumptive cases know their HIV status; Scenario E: adherence (100%) to algorithms; Scenario F: increased proportion (100%) of presumptive cases know their HIV status and adherence (100%) to algorithms; Scenario G: remove culture as part of the sequence of tests required in each diagnostic algorithm; Scenario H: lower the sensitivity of smear microscopy by 10%. TB ¼ tuberculosis.
the analysis for new and previously treated TB cases, and for HIV-positive and HIV-negative TB cases (Appendix Table A .6-A.13).
Analysis
All patient and laboratory test information was written to a Microsoft SQL Server database (MicroSoft, Redmond, WA, USA). Model outputs were aggregated by month over a 3-year period to produce means and 95% confidence intervals (CIs) for diagnostic yield and proportions that were falsenegative and false-positive. We used the t-test to determine differences in means between observed and modelled outputs for the model validation and between algorithms for simulated scenarios. Differences are expressed as absolute values. All analyses were undertaken using STATA version 14 (StataCorp, College Station, TX, USA).
Ethics statement
The study was approved by the Health Research Ethics Committee at Stellenbosch University, Tygerberg, South Africa (IRB0005239) (N10/09/308) and the Ethics Advisory Group at the International Union 
RESULTS
Model validation
The mean differences between observed yield from routine data and model outputs over the seven time points is shown in Figure 1 and Table 2 . The TB yield from the model closely approximated that from routine data for both diagnostic algorithms. The mean model yield was 0.1% (P ¼ 0.928) lower than observed values in the smear/culture-based algorithm and 0.1% (P ¼ 0.874) higher in the Xpert-based algorithm overall ( Figure 1 ; Table 2 ).
Simulated scenarios: comparing the smear/culture and Xpert-based algorithms Figure 2 and Table 3 summarise the model outputs from the scenarios comparing the TB diagnostic yield from the smear/culture and Xpert-based algorithms. In Scenario A (detail in Appendix Table A.6), with 85% adherence to the diagnostic algorithms and where 50% of presumptive cases knew their HIV status, the overall TB diagnostic yield was 15.8% in the smear/culture-based algorithm compared to 17.9% in the Xpert-based algorithm (relative difference 13.3%), with respectively 3.3% and 2.1% of presumptive cases having a missed TB diagnosis. A lower proportion of cases were falsely diagnosed with TB in the smear/culture-based algorithm (0.8%) than in the Xpert-based algorithm (1.6%). When the estimated TB prevalence among presumptive cases was increased by 10% (absolute) (Scenario B) (Appendix Table A.7), the yield was 24.0% and 26.7% in the respective algorithms. The relative increase in yield between algorithms was 11.3%. The proportion of missed cases was respectively 5.1% and 3.1%.
When Scenario A was adjusted so that the proportions of smear-negative and Xpert-negative cases who received a culture test were set to reflect the values found in routine practice (Scenario C), the overall yield was 16.8% in the smear/culture-based algorithm compared to 18.1% in the Xpert-based algorithm, a relative increase of 7.7%. The proportion of missed cases was 2.3% and 1.9% in the respective algorithms (Appendix Table A .8) . In comparison to Scenario A, the relative increase in TB yield was 6.3% in the smear/culture-based algorithm and 1.1% in the Xpert-based algorithm in Scenario C. If HIV testing among presumptive TB cases was increased and 85% knew their HIV status (Scenario D) (Appendix Table A .9), the overall yield was 16.4% in the smear/culture-based algorithm compared to 18.4% in the Xpert-based algorithm (relative difference 12.2%), with 2.6% and 1.5% missed cases in the respective algorithms. In comparison to Scenario A, an increase in HIV testing resulted in a relative increase of 3.8% and 2.8% in TB yield in the respective algorithms.
If adherence to the testing protocol in each algorithm was increased to 100% but only 50% of presumptive TB cases knew their HIV status (Scenario E) (Appendix Table A .10), the TB yield was 16.1% in the smear/culture-based compared to 18.3% in the Xpert-based algorithm, with a relative increase of 10.9%. The proportion of missed cases was respectively 3.0% and 1.8%. In comparison to Scenario A, the relative increase in TB yield was 1.9% in the smear/culture-based algorithm compared to 2.2% in the Xpert-based algorithm.
If adherence to the testing protocol in each algorithm was increased to 100% and 100% of presumptive TB cases knew their HIV status (Scenario F) (Appendix Table A .11), the TB yield was 16.8% in the smear/culture-based compared to 19.0% in the Xpert-based algorithm, with a relative increase of 13.1% between algorithms. The proportion of missed cases was respectively 2.1% and 1.1%. In comparison to Scenario A, the relative increase in TB yield was 6.3% in the smear/culturebased algorithm compared to 6.1% in the Xpertbased algorithm.
Removing culture as part of the testing protocol from both algorithms (Scenario G) (Appendix Table  A .12) resulted in a TB yield of 13.7% and 18.3% in the respective algorithms. The relative increase in yield between algorithms was 33.6%. The proportion of missed cases was 5.4% in the smear/culture algorithm compared to 1.8% in the Xpert algorithm.
If we assume the sensitivity of smear microscopy to be 10% lower than that estimated in our model (Scenario H) (Appendix Table A.13), the yield in the smear/culture algorithm would be 14.7% (missed cases 4.4%), with a relative increase in yield with the Xpert algorithm of 21.8%.
DISCUSSION
A strength of this study was the availability of detailed routine data and information collected on health and laboratory processes, which allowed us to develop a precise operational model to assess the impact of different diagnostic algorithms in Cape Town. The model input parameters were mostly based on these detailed routine data, and only a few assumptions were made. We assumed that prevalence among presumptive cases was higher among HIVpositive presumptive cases than among HIV-negative cases, 18, 19 and among previously treated than among new cases; 20 we assumed a decrease in TB prevalence among presumptive cases over time based on the empiric yield data, which showed a decrease in yield over time despite similar proportions of the population being tested. 16 The latter assumption is supported by national data that showed a decrease in the number of laboratory-confirmed cases since 2011 (nationally and across the Western Cape Province). 21 The availability of routine TB NHLS data collected through the PROVE IT study allowed us to validate the model by comparing TB yield observed in routine practice to model outputs using input parameters from seven different time points during the period when PHC facilities changed from the smear/culture algorithm to the Xpert algorithm. This comparison built confidence in the outputs from the model and confirmed that the outputs were credible. Overall model outputs closely resembled the TB yield observed in Cape Town over the seven time points, with a mean difference of 0.1% (P ¼ 0.951) between routine data and the model outputs.
A direct comparison of TB yield in the Xpert and smear/culture-based algorithms in routine practice is difficult due to the variability in the population characteristic at each time point and different levels of adherence to testing protocols. When the Xpertbased algorithm was newly introduced, it took staff a period of time to adapt their clinical practice and become familiar with the new protocols. The global stock-out of the Xpert test during the study period also played a role in the extent to which testing protocols were followed. The operational model allows a direct comparison between the two algorithms with identical population characteristics and adherence to testing protocols. To understand the mechanisms and the extent to which they influenced TB yield in our setting, we used the validated model to compare various scenarios.
In Scenario A, with 85% adherence to algorithm and 50% of presumptive cases knowing their HIV status, the yield in the Xpert-based algorithm was higher than in the smear/culture-based algorithm, with a relative increase of 13.3%. Although the TB diagnostic yield was higher in the Xpert-based algorithm, the increase was lower than the predicted increase with full roll-out of Xpert in South Africa 10 and reported by other studies. 11, 12 Scenarios B and C provide insights into the findings on TB yield from our empirical study. The TB yield in the smear/culture-based algorithm in Scenario B, where TB prevalence was 10% higher than in Scenario A, was 25% higher than in the Xpert-based algorithm in Scenario A, demonstrating the impact of a decline in prevalence among presumptive TB cases on TB yield. This helps explain findings from the empirical study that reported yields of 20.9% in the smear/culture-based and 17.9% in the Xpert-based algorithm. 16 It is likely that the change in prevalence in our setting during the study period was lower than the 10% value tested in the model.
Our model showed the impact of additional culture testing on reducing the difference in TB yield between algorithms. When the proportions of smear-and Xpert-negative cases who received culture tests were increased to reflect those found in routine practice (Scenario C), the relative increase in yield between the smear/culture and Xpert-based algorithms was reduced to 7.7%. This was attributable to a higher proportion of smear-negative than Xpert-negative cases undergoing culture. A cluster-randomised study in four other provinces also found that culture was more likely to be undertaken for smear-negative (32%) than Xpert-negative (14%) HIV-infected cases. 22 It was proposed that a greater belief in the efficacy of the Xpert test contributed to this. Scenarios D to F provide insights into the potential benefits of interventions that strengthen the health system. Increasing the proportion of presumptive cases who knew their HIV status from 50% to 85% had a small influence on TB yield: the yield increased by 3.8% in the smear/culture-based algorithm, and by 2.8% in the Xpert-based algorithm in relative terms from Scenario A. It is interesting to note the modest benefits, considering the effort required to increase HIV testing of presumptive cases to this extent.
In Scenario E for the Xpert-based algorithm, increasing adherence to the algorithm to 100%, but with only 50% of presumptive TB cases knowing their HIV status, produced a 2.2% relative increase in yield compared to Scenario A. Increasing adherence to 100% and with 100% knowing their HIV status resulted in a relative increase in yield of only 6.1% in the Xpert-based algorithm in Scenario F compared to Scenario A. In addition to this disappointingly small benefit, 100% adherence is not realistic in routine practice due to the failure to request the correct test (due to new or locum staff who are unfamiliar with Xpert and costs concerns, for example), the availability of the Xpert test due to maintenance on Xpert machines or stock-outs and clinical decisions overriding the use of the testing algorithm. It is important to note that we started on a baseline of 85% adherence to the algorithms and with 50% knowing their HIV status; the increases in yield would be greater if these baseline values were lower. In a future study, we will model the effect of a more sensitive test than Xpert to assess the extent to which this can increase TB diagnostic yield.
We compared two scenarios that are pertinent to other settings. In Scenario G, where culture was removed from the algorithms, there was a 33.6% relative difference in TB yield between the smear/ culture and the Xpert-based algorithm. The diagnostic benefits of Xpert are thus likely to be greater in areas that do not use or have very limited use of culture. The performance of smear microscopy in our central laboratory may also be much higher than reported by peripheral microscopy units. This is possibly due to greater proficiency and technical aspects in the central laboratory. It has been shown that an increase in yield for smear microscopy could be achieved by chemical treatment, centrifugation and fluorescence microscopy, [23] [24] [25] as used in our laboratory. If we did not have these benefits and smear microscopy sensitivity was 10% lower, the relative increase in TB yield in the Xpert-based algorithm would have been 21.8% compared to that in the smear/culture-based algorithm.
Limitations
We did not have data on TB prevalence for presumptive cases. This was estimated with a range of values tested in the model. The model was validated against data from Cape Town, a wellresourced urban setting where there is extensive use of culture in both algorithms. This may limit the generalisability of the findings to other settings.
As complete data are rarely available for any modelling study, assumptions are required for some input parameters. A model is also, by definition, a simplification of real-life processes. In this study, our model was validated by running the model with input parameters based on routine data for seven individual time points and comparing the output from the model against corresponding routine data ( Figure 1 ; Table  2 ). Cost implications, treatment delay and rifampicin resistance were not addressed in the current study and will be reported in future studies.
CONCLUSION
We have developed and validated an operational model that can be used to directly compare the TB diagnostic yield between different algorithms, i.e., a smear/culture-based and an Xpert-based algorithm. Our model accounted for the variability found in routine practice and made it possible to eliminate the effect of a difference in population characteristics and adherence to testing protocols within algorithms on the TB diagnostic yield.
Modelling TB diagnostic algorithms
We were able to show that extensive use of culture in the smear/culture-based algorithm and decline in TB prevalence are the main factors likely to have contributed to our not finding an increased TB yield in the Xpert-based algorithm in our empiric study. The Xpert-based algorithm is likely to yield greater diagnostic benefits in areas without culture or with less sensitive TB microscopy.
We have demonstrated the benefits of using an operational model to determine the effect of scaling up a new diagnostic algorithm and investigate the mechanistic reasons that influence the yield of a new TB diagnostic algorithm. We would therefore recommend that policy makers use operational modelling to make appropriate decisions before new diagnostic algorithms are scaled up. The model could provide evidence as to how the greatest benefits could be obtained by using a new diagnostic test within a TB diagnostic algorithm and in a specific setting.
APPENDIX
Modelling as a framework to help with decision making is an attractive and viable option to guide policy makers in implementing new diagnostic tools and diagnostic algorithms. Two modelling approaches previously used in tuberculosis (TB) control are transmission (epidemiological) modelling and operational modelling. 1 Transmission modelling can be used to predict the long-term impact of interventions on the community by projecting TB incidence, prevalence and mortality. Operational modelling, on the other hand, can be used to project the impact of interventions on health system costs and infrastructure, as well as patient access and outcomes. Operational modelling can also be useful in identifying gaps within a health system and to identify ways to address the gaps within the health system. 2 An operational model is a simplified representation of complex real-life processes. The data sources usually used to drive operational models are derived from published literature (i.e., meta-analyses, randomised control trials, cohort studies, global reports, unpublished literature, expert opinion, field data), and from assumptions. Models are therefore only as good as the level of detail available to develop the logic of the model and the availability and accuracy of the data to drive the model. 3 In industrial and commercial settings, operational models are widely used to plan and assess the performance and efficiency of processes. 4 Operational models have also increasingly been used to improve performance of the health sector. 5, 6 The use of operational models in health systems is common in high-income countries, but not in middle-to lowincome countries at this stage. Many operational models use a discrete event simulation approach, where the system modelled is first defined in terms of its most important elements, including the items or people processed through the facility, resources, activities, rules and the process flow. The required outputs of the model are defined (e.g., productivity, costs, identification of bottlenecks, capacity and sensitivity to changes), along with the key input parameters to be investigated. Once the system is defined and appropriate parameter inputs are assigned (e.g., the number of items entering the system, the quantity of resources and the time for completing particular activities), then simulations can be run to assess the relative effect of different input assumptions on the modelled outputs. 7 
Model development
The Witness package, a discrete event and continuous process simulator, 8 The main elements in the model (Table A. 1) were entities (representing patients, sputum samples), activities (representing patient reception, sputum collection from the patient, sample transport, sample registration at the laboratory, sample preparation and test procedures, review and return of results to primary health care [PHC] facilities), queues (representing delays before each activity, e.g., patient waiting in reception prior to clinical evaluation and sputum collection, batching and other processes in Modelling TB diagnostic algorithms i the laboratory) and resources (representing health facility and laboratory staff and equipment).
The model structure follows the patient and sample pathways ( Figure A.2) , with the flow of entities between activities and queues dictated by rules, which are dependent on attributes for entities (patient or sample).
Input parameters
A detailed list of the input parameters, including processing times, patient and sample data as well as test sensitivity and specificity, is shown in Table A. 2.
Input data sources
Health system and laboratory processes were mapped in three ways: through key informant interviews, through the review of standard operating procedures and through detailed observation and timing of clinic and laboratory processes, all undertaken as part of the PROVE IT study.
Characteristics of presumptive cases were derived from electronic laboratory TB test data received from the National Health Laboratory Services (NHLS) Data Warehouse. Data included demographic information, treatment history (new or previously treated cases) human immunodeficiency virus (HIV) status (HIV-negative, HIV-positive, status unknown), test type (smear, culture or Xpert w MTB/RIF), test results and date when sputum was collected, tested and results available.
As there were no unique identifiers in the NHLS data to link results belonging to an individual, matching was performed on personal identifying information (first name, family name, date of birth and facility folder number). After record matching, all personal identifying information was removed. These data were used to assess adherence to testing protocols in each algorithm and to calculate diagnostic yield (the proportion of presumptive cases diagnosed as TB). Data on the sensitivity and specificity of tests were obtained from systematic reviews and published literature. [9] [10] [11] We did not have data on the proportion of true TB cases among presumptive cases (TB prevalence), and we tested a range of prevalence values, assuming that prevalence was lower among HIV-negative than among HIV-positive, 12, 13 and among new than among previously treated presumptive cases 14 ; the outputs in comparison to observed TB yield values from routine data were then assessed (see below). 15 
Model outputs
The output from the model indicated the proportion of cases diagnosed as TB (TB yield, i.e., true-positive and false-positive cases) and the proportion of cases missed (false-negative) using the diagnostic algorithm in different scenarios.
Model calibration and validation
To have confidence in the model and the outputs produced, the model was verified and validated. 16 Model verification to ensure that the coding and logic of the model and its execution were correct was performed through incremental model building and carefully scrutinising the structure and logic of the model at each stage. The distribution of input parameters was assessed against outputs to make sure that the model assigned patient categories correctly.
The model was validated using input parameters from routine data and by comparing TB yield from model outputs to routine data. 15 As part of the PROVE IT Study, NHLS data from presumptive cases had previously been collected and analysed to compare TB yield in the smear/culture-based algorithm to that in the Xpert-based algorithm over seven time periods (T1-T7), during which the PHC changed from the former algorithm to the latter. 15 The model used probability distributions derived from this analysis to assign patients to categories: diagnostic algorithm used, HIV status (known HIV-positive, undiagnosed HIV and HIVnegative) and treatment history (new or previously treated).
Data on HIV status were only available for time points T6 and T7 (50% knew their HIV status), and similar proportions were assumed for T1-T5. The extent to which testing protocols was followed in each diagnostic algorithm was derived from these data. As we did not have data on TB prevalence among presumptive cases, a range of values were tested. We made the assumption that prevalence among presumptive cases was higher among HIV-positive presumptive cases than among HIV-negative cases, 12, 13 and among previously treated than among new cases. 14 We assumed a decrease in TB prevalence among presumptive cases based on the routine yield data, which showed a decrease in yield over time despite a similar proportion of the population being tested. 15 This is supported by national data that show a reduction in the number of laboratory-confirmed cases since 2011 (nationally and across the Western Cape Province). 17 A summary of the population characteristics used for model validation by time period is provided in Table  A. 3.
The availability of TB test data collected through the PROVE IT study allowed us to validate the model by comparing TB yield observed in routine practice to model outputs using the input parameters from seven different time points during the period when PHC facilities changed from the smear/culture algorithm to *T1-T7 reflect the time points evaluated as part of a non-randomised stepped-wedge evaluation of TB yield with a transition from a smear/culture to an Xpertbased algorithm in Cape Town. 15 At T1 and T2, all facilities used the smear/culture-based algorithm; this decreased to 65% of facilities at T3, 38% at T4 and 23% at T5. At T6 and T7, all facilities used the Xpert- Modelling TB diagnostic algorithms v the Xpert algorithm. This comparison built confidence in the outputs from the model, and confirmed that the outputs were credible. Overall model outputs closely resembled TB yield observed in Cape Town over the seven time points, with a mean difference of 0.0% (P ¼ 0.988) between the routine data and the model outputs (Table 2) .
Model sensitivity analysis
We selected five parameters to test the sensitivity of our results to uncertainty in the parameter values. The parameters evaluated were the estimated TB prevalence among presumptive cases, the proportion of presumptive cases with previous anti-tuberculosis treatment, the test sensitivity of smear microscopy and Xpert, the proportion of adherence to testing algorithms and the extent of use of culture. These parameters were selected because they have a direct impact on the probability of being correctly tested with TB, and therefore an impact on the primary outputs, i.e., diagnosed as TB (TB yield), missed cases (false-negative) and unnecessarily treated cases (falsepositive).
This analysis is summarised in Tables A.14 and A.15 as well as in Figures A.3 and A. 4. The analysis shows that TB diagnostic yield is sensitive to TB prevalence among presumptive cases and, to a lesser extent, to test sensitivity and previous history of TB. The proportion of HIV-positive cases among presumptive cases had more of an effect on the Xpertbased algorithm, with a decrease in yield as the proportion of HIV-positive cases increased. Se creó un modelo operativo del proceso diagnóstico de la tuberculosis (TB) y se evaluó inicialmente con el algoritmo de la baciloscopia y el cultivo y luego con el algoritmo que incluía la prueba Xpert. Se simularon modelos con diferentes hipótesis de prevalencia de TB, adhesión a los algoritmos y situación frente a la infección por el virus de la inmunodeficiencia humana. Estos modelos permitieron una comparación directa del rendimiento diagnóstico de ambos algoritmos. R E S U L T A D O S: Los datos de la prá ctica corriente pusieron de manifiesto que el rendimiento diagnóstico disminuyó durante el período de despliegue del algoritmo con la prueba Xpert en comparación con el rendimiento que se lograba cuando se aplicaba el algoritmo de la baciloscopia y el cultivo. Sin embargo, al utilizar la modelización en idénticas condiciones, se obtuvo un aumento de 13,3% del rendimiento diagnóstico del algoritmo con la prueba Xpert en comparación con el algoritmo de la baciloscopia y el cultivo. La modelización reveló que un uso extenso del cultivo en el algoritmo de la baciloscopia y el cultivo y la disminución de la prevalencia de TB fueron los principales factores que explicaban el hecho de no haber logrado un mejor rendimiento diagnóstico en los datos de la prá ctica corriente con la prueba Xpert. C O N C L U S I Ó N: En el presente estudio se demuestra la utilidad de un modelo operativo diseñado con el propósito de determinar el efecto de la ampliación de escala de un nuevo algoritmo diagnóstico y se recomienda que las instancias normativas apliquen la modelización operativa a fin de adoptar las decisiones apropiadas, antes de ampliar la escala de nuevos algoritmos diagnósticos.
